Histidine-Rich Glycoprotein Modulation of Immune/Autoimmune, Vascular, and Coagulation Systems
- 25 January 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Reviews in Allergy & Immunology
- Vol. 34 (3), 307-312
- https://doi.org/10.1007/s12016-007-8058-6
Abstract
Histidine-rich glycoprotein (HRG) is plasma glycoprotein that has a multidomain structure, interacts with many ligands, and exhibit many modulatory functions in diverse biological systems. HRG ligands include Zn2+, tropomyosin, heparin and heparan sulphate, plasminogen, plasmin, fibrinogen, thrombospondin, IgG, FcgR, and complement. In many cases, the histidine-rich region of the molecule enhances ligand binding after interaction with Zn2+ or exposure to low pH, conditions associated with sites of tissue injury or tumor growth. The multidomain nature of HRG and diverse ligand binding properties indicates that it can act as an extracellular adaptor protein, bridging together different ligands mainly on cell surfaces. Apart from cell surface molecules, HRG can differentially target IgG, preventing generation of insoluble immune complexes. HRG binds to most cells primarily via heparan sulphate proteoglycans. HRG can enhance clearance of apoptotic and necrotic phagocytes as well as immune complexes. The anti-angiogenic properties of HRG are well established in vitro and in vivo. HRG can modulate other physiological processes such as cell adhesion and migration, fibrinolysis and coagulation, complement activation. This review presents an update on the molecular, structural, biological, and clinical properties of HRG and associated autoimmunity conditions.Keywords
This publication has 37 references indexed in Scilit:
- Contribution of histidine-rich glycoprotein in clearance of immune complexes and apoptotic cells: Implications for ameliorating autoimmune diseasesAutoimmunity, 2007
- Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesionsExperimental Cell Research, 2006
- Apoptotic cells, autoantibodies, and the role of HMGB1 in the subcellular localization of an autoantigenJournal of Autoimmunity, 2005
- Histidine-rich Glycoprotein Specifically Binds to Necrotic Cells via Its Amino-terminal Domain and Facilitates Necrotic Cell PhagocytosisJournal of Biological Chemistry, 2005
- The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoproteinMatrix Biology, 2004
- A Fragment of Histidine-Rich Glycoprotein Is a Potent Inhibitor of Tumor VascularizationCancer Research, 2004
- Two‐chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5The FASEB Journal, 2000
- Mechanisms of angiogenesisNature, 1997
- Complex formation of platelet thrombospondin with histidine-rich glycoprotein.JCI Insight, 1984
- Humanserumproteine mit hoher Affinität zu Carboxymethylcellulose, II. Physikalisch-chemische und immunologische Charakterisierung eines histidinreichen 3,8S-α2-Glykoproteins (CM-Protein I)Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1972